Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-10-01

FDA Approved: RAMIPRIL — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Ramipril from Rising Pharma Holdings, Inc., enabling the continued manufacture and distribution of the generic d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramipril (ramipril)

Snippet

SUPPL AP for RAMIPRIL (RAMIPRIL)